Literature DB >> 30553467

A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8.

Hemani Jain1, Dhanlaxmi Shetty2, Hasmukh Jain3, Manju Sengar3, Navin Khattry4, P G Subramanian5.   

Abstract

Hepatosplenic T-cell lymphoma (HSTL) is a rare subtype of peripheral T-cell lymphoma predominantly seen in young males. This disease presents with isolated hepatosplenomegaly and thrombocytopenia with sinusoidal infiltration of liver and sinusal infiltration of spleen. Immunophenotype shows positivity for CD3, CD7, TCRγδ or TCRαβ, CD38 and double negative for CD4, CD8, TdT, CD5, and CD56. Isochromosome 7q with or without trisomy 8 is seen in HSTL. Recently, ring chromosome 7 has also been identified as a new abnormality. We describe the clinical, immunophenotypic and cytogenetic analysis in a 24-year-old woman. We present an unusual case of TCRγδ positive T-cell lymphoma with aberrant expression of CD19, which is a B-cell lymphoid marker, with amplification of 7q region and subsequent formation of ring chromosome 7 and trisomy 8. This is the second case of HSTL, positive for CD19 and first case presenting with ring chromosome 7 and trisomy 8 in a CD19 positive HSTL which is a rare finding in T-cell lymphoma and needs to be explored further.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aberrant expression of CD19; Amplification; Cytogenetics; Hepatosplenic T-cell lymphoma; Ring chromosome

Mesh:

Substances:

Year:  2018        PMID: 30553467     DOI: 10.1016/j.cancergen.2018.06.003

Source DB:  PubMed          Journal:  Cancer Genet


  2 in total

1.  Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.

Authors:  Qian Wang; Yibin Jiang; Qian Zhu; Yishan Duan; Xiaochen Chen; Ting Xu; Zhengming Jin; Caixia Li; Depei Wu; Haiwen Huang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-15       Impact factor: 4.553

2.  Tetrasomy 8 and isochromosome 7q in CD5-positive hepatosplenic T-cell lymphoma with leukemic presentation.

Authors:  Katsuya Yamamoto; Kimikazu Yakushijin; Marika Okuni-Watanabe; Akiko Hashimoto; Hiroshi Matsuoka; Hironobu Minami
Journal:  Int J Hematol       Date:  2019-07-24       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.